DAVID NOVER: Open Payments
NPI 1922046861 · WARRINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,265 in 54 payments from 13 companies in 2025. Trend: 2023 $10,962 · 2024 $18,296 · 2025 $14,265
Honoraria: $11,825Food & beverage: $1,583Travel & lodging: $857
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $13,306 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $198 |
| Otsuka America Pharmaceutical, Inc. | 5 | $177 |
| Supernus Pharmaceuticals, Inc. | 3 | $141 |
| Collegium Pharmaceutical, Inc. | 5 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Lundbeck LLC | 3 | $63 |
| ABBVIE INC. | 3 | $48 |
| Alkermes, Inc. | 2 | $36 |
Products named: Auvelity, REXULTI, CAPLYTA, Qelbree, Jornay PM, TRINTELLIX, COBENFY, VRAYLAR.
Industry payments across PA — which companies pay providers there.
